Napa-001

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameNapa-001
Drug Alias Nameanti-MIF (NapaJen)anti macrophage migration inhibitory factor (NapaJen)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionMacrophage migration inhibitory factor inhibitors
TargetsMacrophage migration inhibitory factor
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNapajen Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNapajen Pharma
Active IndicationsN/A
Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A